» Articles » PMID: 35952624

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Overview
Journal Adv Mater
Date 2022 Aug 11
PMID 35952624
Authors
Affiliations
Soon will be listed here.
Abstract

Despite potent preclinical antitumor activity, activation of stimulator of interferon genes (STING) has shown modest therapeutic effects in clinical studies. Many STING agonists, including 2',3'-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), show poor pharmacokinetic properties for sustaining STING activation in tumors and achieving optimal antitumor efficacy. Improved delivery of STING agonists and their effective combination with other treatments are needed to enhance their therapeutic effects. Herein, a 2D nanoplatform, cGAMP/MOL, is reported via conjugating cGAMP to a nanoscale metal-organic layer (MOL) for simultaneous STING activation and radiosensitization. The MOL not only exhibits strong radiosensitization effects for enhanced cancer killing and induction of immunogenic cell death, but also retains cGAMP in tumors for sustained STING activation. Compared to free cGAMP, cGAMP/MOL elicits stronger STING activation and regresses local tumors upon X-ray irradiation. Further combination with an immune checkpoint inhibitor bridges innate and adaptive immune systems by activating the tumor microenvironment to elicit systemic antitumor responses.

Citing Articles

Metal-organic layer delivers 3-bromopyruvate to mitochondria for metabolic regulation and cancer radio-immunotherapy.

Bian W, Jiang X, Li J, Tillman L, Wang C, Zhen W Chem Sci. 2025; .

PMID: 39991561 PMC: 11843481. DOI: 10.1039/d4sc08563a.


Ca- and cGAMP-Contained Semiconducting Polymer Nanomessengers for Radiodynamic-Activated Calcium Overload and Immunotherapy.

Cheng D, Luo L, Zhang Q, Song Z, Zhan Y, Tu W Adv Sci (Weinh). 2024; 12(6):e2411739.

PMID: 39679909 PMC: 11809400. DOI: 10.1002/advs.202411739.


Cationic Metal-Organic Layer Delivers siRNAs to Overcome Radioresistance and Potentiate Cancer Radiotherapy.

Ma X, Jiang X, Wang Z, Fan Y, Li J, Chow C Angew Chem Int Ed Engl. 2024; 64(7):e202419409.

PMID: 39535730 PMC: 11811689. DOI: 10.1002/anie.202419409.


STING agonist-conjugated metal-organic framework induces artificial leukocytoid structures and immune hotspots for systemic antitumor responses.

Luo T, Jiang X, Fan Y, Yuan E, Li J, Tillman L Natl Sci Rev. 2024; 11(7):nwae167.

PMID: 38887543 PMC: 11182667. DOI: 10.1093/nsr/nwae167.


Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions.

Colangelo N, Gerber N, Vatner R, Cooper B Front Pharmacol. 2024; 15:1383000.

PMID: 38659582 PMC: 11039815. DOI: 10.3389/fphar.2024.1383000.


References
1.
Kang J, Demaria S, Formenti S . Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer. 2016; 4:51. PMC: 5028964. DOI: 10.1186/s40425-016-0156-7. View

2.
Qian J, Schoenfeld J . Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges. Front Oncol. 2021; 10:608772. PMC: 7886974. DOI: 10.3389/fonc.2020.608772. View

3.
Hafner M, Niepel M, Chung M, Sorger P . Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat Methods. 2016; 13(6):521-7. PMC: 4887336. DOI: 10.1038/nmeth.3853. View

4.
Carozza J, Bohnert V, Nguyen K, Skariah G, Shaw K, Brown J . Extracellular cGAMP is a cancer cell-produced immunotransmitter involved in radiation-induced anti-cancer immunity. Nat Cancer. 2021; 1(2):184-196. PMC: 7990037. DOI: 10.1038/s43018-020-0028-4. View

5.
Bowen J, LEVINSON C . Phosphate concentration and transport in Ehrlich ascites tumor cells: effect of sodium. J Cell Physiol. 1982; 110(2):149-54. DOI: 10.1002/jcp.1041100207. View